News | January 20, 2026
Manthan 2026 wraps up, spotlighting India’s life sciences & clinical research future
India in the Changing Landscape of Life-Sciences Research & Development
India in the Changing Landscape of Life-Sciences Research & Development
His professional background also includes key experience at Matrix Labs and Sun Pharma
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
FDA's withholding of the PRV was contrary to law because no drug product containing phenobarbital sodium was 'previously approved'
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Positive volume growth was observed in key therapies such as respiratory (13.2% yoy), anti-neoplastics (12.1% yoy) and cardiac (4.8% yoy) during September 2025
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
The IND application supports the next phase of development of SBO-154
These results represent critical milestones for Philogen, as Fibromun has the potential to become second product to successfully complete multinational clinical trials with registration potential
Subscribe To Our Newsletter & Stay Updated
